Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease

JAMA

Volumn 307, Issue 12, 2012, Pages 1292-1301

  Wahbi, Karim ^a,b,c   Meune, Christophe ^b,d   Porcher, Raphaël ^e,f   Bećane, Henri Marc ^c   Lazarus, Arnaud ^b,g   Laforêt, Pascal ^a,c   Stojkovic, Tanya ^c   Béhin, Anthony ^c   Radvanyi Hoffmann, Hélène ^h   Eymard, Bruno ^a,c   Duboc, Denis ^b,c,d,i  

^a SORBONNE UNIVERSITÉ   (France)

^b Cardiology Department ^*  (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d APHP   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g InParys Clinical Research Group   (France)

^h HÔPITAL AMBROISE PARÉ   (France)

ⁱ Sorbonne Université   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PACING; HUMAN; INTERMETHOD COMPARISON; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; NON INVASIVE PROCEDURE; OVERALL SURVIVAL; PR INTERVAL; PRIORITY JOURNAL; QRS COMPLEX; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL RATE; SURVIVAL TIME; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART FUNCTION TEST; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; REGISTER; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL;

ADULT; ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84859204511     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.346     Document Type: Article

References (31)

1. Ashizawa T, Epstein HF. Ethnic distribution of myotonic dystrophy gene. Lancet. 1991;338(8767):642-643.
2. Mahadevan M, Tsilfidis C, Sabourin L, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science. 1992;255(5049):1253-1255.
3. Mankodi A, Logigian E, Callahan L, et al. Myotonic dystrophy intransgenic mice expressing an expanded CUG repeat. Science. 2000;289(5485):1769-1773.
4. Amack JD, Paguio AP, Mahadevan MS. CIs and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model. Hum Mol Genet. 1999;8(11):1975-1984. (Pubitemid 29458723)
5. de Die-Smulders CE, Höweler CJ, Thijs C, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain. 1998;121(pt 8):1557-1563. (Pubitemid 28349907)
6. Mathieu J, Allard P, Potvin L, Prévost C, Bégin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999;52(8):1658-1662. (Pubitemid 29220644)
7. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med. 2008;358(25):2688-2697. (Pubitemid 351860861)
8. Zipes DP, Camm AJ, Borggrefe M, et al; European Heart Rhythm Association; Heart Rhythm Society; American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48(5):e247-e346.
9. Gagnon C, Chouinard MC, Laberge L, et al; DMI Expert Panel. Health supervision and anticipatory guidance in adult myotonic dystrophy type 1. Neuromuscul Disord. 2010;20(12):847-851.
10. Epstein AE, DiMarco JP, Ellenbogen KA, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117(21):e350-e408.
11. Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology. 2001;56(3):336-340. (Pubitemid 32144144)
12. Walton J, Rowland L. Clinical examination, differential diagnosis and classification. In: Walton J, Karpati G, Hilton-Jones D, eds. Disorders of Voluntary Muscle. 6th ed. New York, NY: Churchill Livingstone; 1994:1771.
13. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol. 2002;40(9):1645-1652. (Pubitemid 35253643)
14. Lazarus A, Varin J, Ounnoughène Z, et al. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation. 1999;99(8):1041-1046. (Pubitemid 29104494)
15. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515-526.
16. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons; 1980.
17. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34(4):541-554. (Pubitemid 9067879)
18. D'Agostino RB Jr, D'Agostino RB Sr. Estimating treatment effects using observational data. JAMA. 2007;297(3):314-316.
19. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55.
20. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265-2281.
21. Austin PC. Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J. 2009;51(1):171-184.
22. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26(4):734-753. (Pubitemid 46206593)
23. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083-3107.
24. Austin PC, Grootendorst P, Normand SL, Anderson GM. Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study. Stat Med. 2007;26(4):754-768. (Pubitemid 46206594)
25. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10(4):585-598.
26. White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med. 2009;28(15):1982-1998.
27. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101-121.
28. R Foundation for Statistical Computing; R Development Core Team. R: A Language and Environment for Statistical Computing. http://www.R-project.org. Accessed February 14, 2012.
29. Sekhon JS. Multivariate and propensity score matching software with automated balance optimization: the Matching Package for R. J Stat Softw. 2011;42(7):1-52.
30. van Buuren S, Oudshoorn CGM. MICE: Multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45(3):1-67.
31. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34(3):618-620. (Pubitemid 29436163)